ClinicalTrials.Veeva

Menu

The Brain Health Study: A Pragmatic, Patient-Centered Trial (eRADAR)

University of California San Francisco (UCSF) logo

University of California San Francisco (UCSF)

Status

Completed

Conditions

Alzheimer Disease
Dementia

Treatments

Other: Brain Health Assessment

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05905796
1R01AG069734 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The eRADAR Brain Health Study seeks to refine and test a novel, low-cost strategy for increasing dementia detection within primary care.

Full description

Detailed description: eRADAR stands for "electronic health record (EHR) Risk of Alzheimer's and Dementia Assessment Rule." It is a low-cost tool or algorithm that uses readily available EHR data elements to identify high-risk patients. The investigators will conduct a pragmatic randomized controlled trial to assess the impact of implementing eRADAR as part of a supported outreach process on dementia detection rates. The investigators will also explore the impact of eRADAR implementation on healthcare utilization and patient experience.

Enrollment

1,271 patients

Sex

All

Ages

65+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • No prior diagnosis of dementia (defined from EHR diagnosis codes) and not receiving medications for dementia
  • Active patient at participating clinic
  • Adequate data to calculate eRADAR score

Exclusion criteria

- Currently receiving hospice care

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

1,271 participants in 2 patient groups

Brain Health Intervention
Experimental group
Description:
Calculate eRADAR scores using EHR data to identify eligible individuals Invite eligible individuals for brain health assessment visit Enter results of brain health assessment visit into EHR Provide summary of results and recommended next steps to the Primary Care Physician and participant
Treatment:
Other: Brain Health Assessment
Usual Care
No Intervention group
Description:
Usual care Individuals who meet eligibility criteria will receive usual care.

Trial contacts and locations

3

Loading...

Central trial contact

Alana Elop, MS; Leonardo Colemon, MA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems